6
Oct
2026
Dongkook Pharmaceutical Co., Ltd.
Exhibitor at CPHI Milan 2026 stand 14C68, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:Korea, Republic Of
-
Founded:1968
-
On CPHI since:2015
-
Employees:1000 - 4999
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 14C68, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Liposomal Amphotericn B Injection
Anti-fungal polyene antibiotics produced from a strain of Streptomyces nodosus -
Product Leuprolide Acetate Injection
LHRH analogue for endometriosis, prostatic cancer, and central precocious puberty -
Product Octreotide Acetate LAR Injection
Octreotide acetate for acromegaly, carcinoid tumors and VIPoma -
Product Propofol Injection
Dongkook Pharm. Co. Ltd offers a wide range of pharmaceutical products which includes propofol injection. Active ingredients: pofol injection contains propofol 10mg per ml. Indications: induction and maintenance of general anaesthesia, sedation of ventilated patients receiving intensive care. Shelf life: 3... -
Product Teicoplanin Injection
Dongkook Pharm. Co. Ltd offers a wide range of pharmaceutical products which includes teicoplanin injection. Active ingredients: 1 vial contains teicoplanin 200mg / 400mg. Indications: skin and soft tissue infections, urinary tract infections, lower respiratory tract infections, joint and bone infections, ...
